Literature DB >> 3535863

Recovery of cell subpopulations from human tumour xenografts following dissociation with different enzymes.

M J Allalunis-Turner, D W Siemann.   

Abstract

Human epidermoid tumours (Co112, HEp3, A431, ME180) grown in nude mice were dissociated using four different enzyme cocktails: 0.025% collagenase, 0.05% pronase, 0.04% DNase; 0.1% protease IX; 0.14% trypsin, 0.04% DNase; 0.025% collagenase, 0.02% DNase. Using these different enzymatic procedures, the total cell yields, host to tumour cell ratios, plating efficiencies and cell cycle distribution profiles obtained from each tumour model were compared. For all tumours tested, enzyme cocktail 1 was the most effective in releasing the greatest total number of cells g-1 tumour. However, for each tumour the percentage of neoplastic cells recovered, the plating efficiency and the cell cycle distributions varied according to the enzyme cocktail used to dissociate the tumour. For example, for HEp3 tumours, the highest plating efficiency was achieved using enzyme cocktail 4, whereas for ME180 tumours, this enzyme cocktail produced the lowest plating efficiency. Further, the effect of lethally irradiated (HR) feeder cells on the plating efficiency of the various tumours was found to be influenced by the enzymes chosen to dissociate the tumours. These studies indicate that the choice of an enzyme dissociation technique may profoundly influence the results obtained using human tumour xenografts.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3535863      PMCID: PMC2001505          DOI: 10.1038/bjc.1986.217

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  12 in total

1.  Transplantable human neoplasms maintained in cortisone-treated laboratory animals: H.S. No. 1; H.Ep. No. 1; H.Ep. No. 2; H.Ep. No. 3; and H.Emb.Rh. No. 1.

Authors:  H W TOOLAN
Journal:  Cancer Res       Date:  1954-10       Impact factor: 12.701

2.  Some properties of a new epithelial cell line of human origin.

Authors:  J A Sykes; J Whitescarver; P Jernstrom; J F Nolan; P Byatt
Journal:  J Natl Cancer Inst       Date:  1970-07       Impact factor: 13.506

3.  Multi-user system for analysis of data from flow cytometry.

Authors:  J Fried; M Mandel
Journal:  Comput Programs Biomed       Date:  1979-12

4.  Biology of the A-431 cell: a useful organism for hormone research.

Authors:  C M Stoscheck; G Carpenter
Journal:  J Cell Biochem       Date:  1983       Impact factor: 4.429

5.  Response of an in vivo-in vitro tumour to X-rays and cytotoxic drugs: effect of tumour disaggregation method on cell survival.

Authors:  J S Rasey; N J Nelson
Journal:  Br J Cancer Suppl       Date:  1980-04

6.  Inflammatory cells in solid murine neoplasms. I. Tumor disaggregation and identification of constituent inflammatory cells.

Authors:  S W Russell; W F Doe; R G Hoskins; C G Cochrane
Journal:  Int J Cancer       Date:  1976-09-15       Impact factor: 7.396

7.  Cloning of human lung cancer cells.

Authors:  G A Walls; P R Twentyman
Journal:  Br J Cancer       Date:  1985-10       Impact factor: 7.640

8.  Disaggregation of human solid tumours by combined mechanical and enzymatic methods.

Authors:  S A Engelholm; M Spang-Thomsen; N Brünner; I Nøhr; L L Vindeløv
Journal:  Br J Cancer       Date:  1985-01       Impact factor: 7.640

9.  Cell subpopulations dispersed from solid tumours and separated by centrifugal elutriation.

Authors:  D W Siemann; E M Lord; P C Keng; K T Wheeler
Journal:  Br J Cancer       Date:  1981-07       Impact factor: 7.640

Review 10.  Human tumour xenografts: a critical appraisal.

Authors:  G G Steel; M J Peckham
Journal:  Br J Cancer Suppl       Date:  1980-04
View more
  11 in total

1.  Adaptation of an automated selective dissociation procedure to two novel spheroid types.

Authors:  L A Kunz-Schughart; J P Freyer
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-02       Impact factor: 2.416

2.  The in situ tumour response to combinations of cyclophosphamide and tirapazamine.

Authors:  D W Siemann
Journal:  Br J Cancer Suppl       Date:  1996-07

3.  Improved technique for establishing short term human brain tumor cultures.

Authors:  M A Farr-Jones; I F Parney; K C Petruk
Journal:  J Neurooncol       Date:  1999-05       Impact factor: 4.130

4.  Cytokinetic effects of Wee1 disruption in pancreatic cancer.

Authors:  Qing Chang; Megha Chandrashekhar; Troy Ketela; Yaroslav Fedyshyn; Jason Moffat; David Hedley
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

5.  Differentiation patterns in two- and three-dimensional culture systems of human squamous carcinoma cell lines.

Authors:  R Knuechel; P Keng; F Hofstaedter; V Langmuir; R M Sutherland; D P Penney
Journal:  Am J Pathol       Date:  1990-09       Impact factor: 4.307

6.  Immune-based antitumor effects of BRAF inhibitors rely on signaling by CD40L and IFNγ.

Authors:  Ping-Chih Ho; Katrina M Meeth; Yao-Chen Tsui; Bhaskar Srivastava; Marcus W Bosenberg; Susan M Kaech
Journal:  Cancer Res       Date:  2014-04-15       Impact factor: 12.701

Review 7.  Importance of orthotopic implantation for human tumors as model systems: relevance to metastasis and invasion.

Authors:  C Manzotti; R A Audisio; G Pratesi
Journal:  Clin Exp Metastasis       Date:  1993-01       Impact factor: 5.150

8.  An optimized disaggregation method for human lung tumors that preserves the phenotype and function of the immune cells.

Authors:  Jon G Quatromoni; Sunil Singhal; Pratik Bhojnagarwala; Wayne W Hancock; Steven M Albelda; Evgeniy Eruslanov
Journal:  J Leukoc Biol       Date:  2014-10-30       Impact factor: 4.962

9.  Anomalous patterns of nitroimidazole binding adjacent to necrosis in human glioma xenografts: possible role of decreased oxygen consumption.

Authors:  M B Parliament; A J Franko; M J Allalunis-Turner; B W Mielke; C L Santos; B G Wolokoff; J R Mercer
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  Modulation of oxygen consumption rate and vascular endothelial growth factor mRNA expression in human malignant glioma cells by hypoxia.

Authors:  M J Allalunis-Turner; A J Franko; M B Parliament
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.